Carolien Boeckx

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Optimal Evaluation of Programmed Death Ligand-1 on Tumor Cells Versus Immune Cells Requires Different Detection Methods.

Optimal Evaluation of Programmed Death Ligand-1 on Tumor Cells Versus Immune Cells Requires Different Detection Methods.

Journal: Archives of pathology & laboratory medicine

Published: April 03, 2018

Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system.

Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system.

Journal: Histopathology

Published: June 14, 2016

Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.

Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.

Journal: American journal of cancer research

Published: March 21, 2015

The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.

The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.

Journal: BMC research notes

Published: November 13, 2014

Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins.

Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins.

Journal: Cancer letters

Published: March 29, 2014

Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response.

Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response.

Journal: BMC research notes

Published: March 23, 2014

Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance.

Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance.

Journal: The oncologist

Published: July 04, 2013

Expression analysis on archival material revisited: isolation and quantification of RNA extracted from FFPE samples.

Expression analysis on archival material revisited: isolation and quantification of RNA extracted from FFPE samples.

Journal: Diagnostic molecular pathology : the American journal of surgical pathology, part B

Published: February 02, 2013

The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.

The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.

Journal: Current pharmaceutical design

Published: August 15, 2012

Expression analysis on archival material: comparison of 5 commercially available RNA isolation kits for FFPE material.

Expression analysis on archival material: comparison of 5 commercially available RNA isolation kits for FFPE material.

Journal: Diagnostic molecular pathology : the American journal of surgical pathology, part B

Published: November 18, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026